Concepedia

Increased Th17 activation and gut microbiota diversity are associated with pembrolizumab-triggered tuberculosis

Yunbin Zhang, Shijia Liu, Zhidong Hu, Jixue Zhou, Yinzhen Wang, Bing Fang, Ka‐Wing Wong, Fan Xia

Cancer Immunology Immunotherapy · 2020 · 15 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa et al. · Science · 2017 · 5.4K citations

, , +17

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Luigi Nezi, Alexandre Reuben et al. · Science · 2017 · 4.7K citations · Full text

, , +17

ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy

Ya‐Ru Miao, Qiong Zhang, Qian Lei et al. · Advanced Science · 2020 · 1K citations · Full text

, , +17

Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype

Leopoldo N. Segal, José C. Clemente, Jun-Chieh J. Tsay et al. · Nature Microbiology · 2016 · 692 citations · Full text

, , +17

Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis

Shinji Kagami, Heather L. Rizzo, Jennifer J. Lee et al. · Journal of Investigative Dermatology · 2009 · 629 citations · Full text

, , +12